Literature DB >> 9182249

GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.

T Nagatsu1, H Ichinose.   

Abstract

Catecholamine biosynthesis is regulated by tyrosine hydroxylase (TH) requiring tetrahydrobiopterin (BH4) as the cofactor. We found four (human TH type 1-4) and two isoforms (TH type 1 and 2) in humans and monkeys, while non-primate animals have a single TH corresponding to human TH type 1. BH4 is synthesized from GTP, and GTP cyclohydrolase I (GCH) is the first and regulatory enzyme. Mutations in GCH gene were found to cause both GCH deficiency with autosomal recessive trait and hereditary progressive dystonia with marked diurnal fluctuation (HPD) (Segawa's disease)/or DOPA-responsive dystonia (DRD) with autosomal dominant trait. When GCH activity is decreased to less than 20% of the normal value, the activity of TH in the nigrostriatal dopaminergic neurons may be first decreased resulting in decreases in TH activity and dopamine level, and in the symptoms of HPD/DRD. In contrast to HPD/DRD, juvenile parkinsonism (JP) have normal GCH activity. In Parkinson's disease (PD), GCH, TH, and dopamine in the striatum may decrease in parallel, as the secondary effects caused by cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9182249     DOI: 10.1007/BF02529141

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  41 in total

1.  TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

Authors:  T NAGATSU; M LEVITT; S UDENFRIEND
Journal:  J Biol Chem       Date:  1964-09       Impact factor: 5.157

2.  THE STRUCTURE OF THE PHENYLALANINE-HYDROXYLATION COFACTOR.

Authors:  S KAUFMAN
Journal:  Proc Natl Acad Sci U S A       Date:  1963-12       Impact factor: 11.205

3.  Structure of the human tyrosine hydroxylase gene: alternative splicing from a single gene accounts for generation of four mRNA types.

Authors:  K Kobayashi; N Kaneda; H Ichinose; F Kishi; A Nakazawa; Y Kurosawa; K Fujita; T Nagatsu
Journal:  J Biochem       Date:  1988-06       Impact factor: 3.387

Review 4.  Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin.

Authors:  C A Nichol; G K Smith; D S Duch
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 5.  Genes for human catecholamine-synthesizing enzymes.

Authors:  T Nagatsu
Journal:  Neurosci Res       Date:  1991-10       Impact factor: 3.304

Review 6.  Dopa-responsive dystonia.

Authors:  T G Nygaard; C D Marsden; R C Duvoisin
Journal:  Adv Neurol       Date:  1988

7.  Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene.

Authors:  H Ichinose; T Ohye; E Takahashi; N Seki; T Hori; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.

Authors:  G C Davis; A C Williams; S P Markey; M H Ebert; E D Caine; C M Reichert; I J Kopin
Journal:  Psychiatry Res       Date:  1979-12       Impact factor: 3.222

9.  GTP cyclohydrolase I gene in hereditary progressive dystonia with marked diurnal fluctuation.

Authors:  H Ichinose; T Ohye; M Segawa; Y Nomura; K Endo; H Tanaka; S Tsuji; K Fujita; T Nagatsu
Journal:  Neurosci Lett       Date:  1995-08-18       Impact factor: 3.046

10.  Recombinant human tyrosine hydroxylase types 1-4 show regulatory kinetic properties for the natural (6R)-tetrahydrobiopterin cofactor.

Authors:  S Nasrin; H Ichinose; H Hidaka; T Nagatsu
Journal:  J Biochem       Date:  1994-08       Impact factor: 3.387

View more
  5 in total

Review 1.  Mutational and biochemical analysis of dopamine in dystonia: evidence for decreased dopamine D2 receptor inhibition.

Authors:  R D Todd; J S Perlmutter
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

Review 2.  GCH1, BH4 and pain.

Authors:  Alban Latremoliere; Michael Costigan
Journal:  Curr Pharm Biotechnol       Date:  2011-10       Impact factor: 2.837

Review 3.  Role of RNA modifications in brain and behavior.

Authors:  Y Jung; D Goldman
Journal:  Genes Brain Behav       Date:  2018-03       Impact factor: 3.449

4.  Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2.

Authors:  Maciej S Lesniak; Betty M Tyler; Drew M Pardoll; Henry Brem
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

Review 5.  Lost in Translation: Defects in Transfer RNA Modifications and Neurological Disorders.

Authors:  Andrea Bednářová; Marley Hanna; Isabella Durham; Tara VanCleave; Alexis England; Anathbandhu Chaudhuri; Natraj Krishnan
Journal:  Front Mol Neurosci       Date:  2017-05-09       Impact factor: 5.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.